Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1651 to 1665 of 2208 results for guidelines

  1. Community engagement (PH9)

    This guidance has been updated and replaced by NICE guideline NG44.

    Public health guideline
    Published
    27 February 2008

  2. Substance misuse interventions for vulnerable under 25s (PH4)

    This guidance has been updated and replaced by NICE guideline NG64.

    Public health guideline
    Published
    28 March 2007

  3. Sexually transmitted infections and under-18 conceptions: prevention (PH3)

    This guidance has been updated and replaced by NICE guideline NG221.

    Public health guideline
    Published
    28 February 2007

  4. HIV testing: increasing uptake in black Africans (PH33)

    This guidance has been updated and replaced by NICE guideline NG60.

    Public health guideline
    Published
    23 March 2011

  5. Looked-after children and young people (PH28)

    This guidance has been updated and replaced by NICE guideline NG205.

    Public health guideline
    Published
    19 October 2010

  6. The clinical effectiveness and cost effectiveness of new drugs for bipolar disorder (TA66)

    This guidance has been updated and replaced NICE guideline CG38.

    Technology appraisal guidance
    Published
    24 September 2003

  7. MI – secondary prevention: Secondary prevention in primary and secondary care for patients following a myocardial infarction (CG48)

    This guidance has been updated and replaced by NICE guideline CG172.

    Clinical guideline
    Published
    23 May 2007

  8. The clinical effectiveness and cost effectiveness of bupropion (Zyban) and Nicotine Replacement Therapy for smoking cessation (TA39)

    This guidance has been updated and replaced by NICE guideline PH10. 

    Technology appraisal guidance
    Published
    27 March 2002

  9. Guidance on the use of vinorelbine for the treatment of advanced breast cancer (TA54)

    This guidance has been updated and replaced by NICE guideline CG81.

    Technology appraisal guidance
    Published
    13 December 2002

  10. The clinical effectiveness and cost effectiveness of surgery for people with morbid obesity (TA46)

    This guidance has been updated and replaced by NICE guideline CG43.

    Technology appraisal guidance
    Published
    19 July 2002

  11. Denosumab for the treatment of therapy-induced bone loss in non-metastatic prostate cancer (terminated appraisal) (TA194)

    This guidance has been updated and replaced by NICE guideline CG175.

    Technology appraisal guidance
    Published
    28 July 2010

  12. The clinical effectiveness and cost effectiveness of newer atypical antipsychotic drugs for schizophrenia (TA43)

    This guidance has been updated and replaced by NICE guideline CG82.

    Technology appraisal guidance
    Published
    26 June 2002

  13. Guidance on the use of patient-education models for diabetes (TA60)

    This guidance has been replaced by NICE guideline NG17.

    Technology appraisal guidance
    Last updated
    1 August 2015

  14. Guidance on the use of long‑acting insulin analogues for the treatment of diabetes – insulin glargine (TA53)

    This guidance has been replaced by NICE guideline NG17.

    Technology appraisal guidance
    Last updated
    1 August 2015

  15. Acute kidney injury: prevention, detection and management (CG169)

    This guidance has been updated and replaced by NICE guideline NG148.

    Clinical guideline
    Published
    28 August 2013